| 000 | 01180 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250510210825.0 | ||
| 264 | 0 | _c19771130 | |
| 008 | 197711s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(77)92516-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarek, J | |
| 245 | 0 | 0 |
_aCyproheptadine in Cushing's syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1977 |
||
| 300 |
_a653-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter | ||
| 650 | 0 | 4 |
_a17-Hydroxycorticosteroids _xmetabolism |
| 650 | 0 | 4 | _aAdrenal Cortex Function Tests |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
| 650 | 0 | 4 |
_aCushing Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aCyproheptadine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetyrapone _xpharmacology |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 700 | 1 | _aMatys, Z | |
| 700 | 1 | _aGregorová, I | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8039 _gp. 653-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(77)92516-8 _zAvailable from publisher's website |
| 999 |
_c69586 _d69586 |
||